CareDx Completes Acquisition of Cancer Diagnostic Company
The deal adds a blood-based test for viral-mediated cancers to the company’s portfolio of transplant and cell therapy services.
The deal adds a blood-based test for viral-mediated cancers to the company’s portfolio of transplant and cell therapy services.
The new service supports transplantation medicine for 13 million people across Northern California and Northern Nevada.
The funding, allocated to the Centers for Disease Control and Prevention, aims to establish more accurate normal ranges for children’s medical results.
Laboratories must now pay fees online and access certificates electronically as the program ends paper mailings.
The settlement resolves claims that Advanced Pathology Solutions provided illegal incentives to gastroenterology practices and performed unnecessary medical testing.
Lot-to-lot reagent inconsistencies can have significant effects on patient test results.
The funding will support manufacturing and commercial partnerships for a system that analyzes multiple protein targets in less than two hours.
Position your laboratory for the future of hemostasis testing This sponsored white paper explores how advances in automation, workflow optimization, and intelligent coagulation analysis are helping laboratories improve...